Today, Montse de Castellarnau, Scientific & Regulatory Affairs Officer at Asphalion, will be attending the “Workshop on support for orphan medicines development”. The workshop is organized by the EMA and it is aimed to facilitate the development of orphan medicines in neglected disease areas. The virtual event will highlight tools and incentives, such as Orphan designation, Protocol Assistance and the PRIME scheme.
Montse de Castellarnau is Medical writer at Asphalion and will participate in this workshop, where she will have the opportunity to interact with the EMA, as well as with stakeholders involved in orphan drugs development.
Asphalion has more than 20 years of experience on Regulatory procedures, and we can support Stakeholders throughout the drug development, including medicines for orphan diseases. If you would like to know more on how Asphalion can assist you, do not hesitate to contact us at info@asphalion.com.
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
A new technique allows the design of solid materia...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Han desarrollado un estudio para evaluar la correlación entre el teji...
Portal de biotecnología en España
¡Suscríbase a nuestro newsletter para estar al día con las últimas noticias y ofertas!
2013 © Biotech-Spain.com - Site Developments SL. Todos los derechos reservados. Terminos y Condiciones | Política de Privacidad
Articles
Directory